bupropion has been researched along with methylphenidate in 54 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (5.56) | 18.7374 |
| 1990's | 6 (11.11) | 18.2507 |
| 2000's | 20 (37.04) | 29.6817 |
| 2010's | 21 (38.89) | 24.3611 |
| 2020's | 4 (7.41) | 2.80 |
| Authors | Studies |
|---|---|
| Ahman, M; Holmén, AG; Wan, H | 1 |
| Aggarwal, S; Foster, JD; Huang, Y; Lapinsky, DJ; Lever, JR; Surratt, CK; Vaughan, RA | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Alelyunas, YW; Bui, K; Empfield, JR; McCarthy, D; Pelosi-Kilby, L; Shen, C; Spreen, RC | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Salzman, C | 1 |
| Reimherr, FW; Wender, PH | 1 |
| Bergman, J; Johnson, SE; Madras, BK; Spealman, RD | 1 |
| Bero, L; Moore, KE; Nielsen, JA; Shannon, NJ | 1 |
| Breese, GR; Mueller, RA; Pappas, BA; Vogel, RA; Wilson, JH | 1 |
| Allen, AJ; Arndt, SV; Barrickman, LL; Herrmann, KJ; Kuperman, S; Perry, PJ; Schumacher, E | 1 |
| Kollins, SH; Pazzaglia, PJ; Rush, CR | 1 |
| Biederman, J | 1 |
| Dogin, JW; Findling, RL | 1 |
| Castaneda, R; Hardy, M; Levy, R; Trujillo, M | 1 |
| Aoun, SL; Bernstein, GA; Crow, SJ; Lewis, BR | 1 |
| Arndt, S; Bever-Stille, KA; Gaffney, GR; Holman, TL; Kuperman, S; Lund, BC; Moser, DJ; Paulsen, JS; Perry, PJ | 1 |
| Brooks, DJ; Evans, SM; Levin, FR; McDowell, DM; Nunes, E | 1 |
| Ickowicz, A | 1 |
| Hume, JH; Kowatch, RA; Kromelis, M; Sethuraman, G; Weinberg, WA | 1 |
| Bohn, AM; Khodaee, M; Schwenk, TL | 1 |
| Biederman, J; Spencer, T; Wilens, T | 1 |
| Reeves, G; Schweitzer, J | 1 |
| Biederman, J; Clark, S; Ditterline, JW; Hammerness, PG; Kwon, A; Moore, H; Morris, MC; Podolski, A; Scott, M; Spencer, TJ; Wilens, TE | 1 |
| Brooks, DJ; Evans, SM; Garawi, F; Kalbag, AS; Levin, FR; Nunes, EV | 1 |
| Awasthi, A; George, AK; Kunwar, AR | 1 |
| Han, C; Joe, SH; Jung, IK; Kim, SH; Ko, YH; Lee, MS; Yang, JW | 1 |
| Bevins, RA; Linkugel, JD; Reichel, CM | 1 |
| Bukstein, O; Szobot, CM | 1 |
| Elkashef, A; Hanson, G; Tiihonen, J; Vocci, F; White, J; Wickes, W | 1 |
| Dopheide, JA; Pliszka, SR | 1 |
| Grabowski, J; Herin, DV; Rush, CR | 1 |
| Abrahamsson, B; Caro, J; Chen, ML; Conner, D; Davit, B; Fackler, P; Farrell, C; Ganes, D; Gupta, S; Katz, R; Mehta, M; Midha, KK; Nambiar, P; Preskorn, SH; Rocci, ML; Sanderink, G; Shah, VP; Stavchansky, S; Temple, R; Thombre, AG; Wang, Y; Winkle, H; Yu, L | 1 |
| Gilman, JP; Goldberg, SR; McCann, DJ; Panlilio, LV; Schindler, CW | 1 |
| Bosch, R; Casas, M; Chalita, PJ; Palomar, G; Prats, L; Ramos-Quiroga, JA; Vidal, R | 1 |
| Calipari, ES; Ferris, MJ; Jones, SR; Mateo, Y; Melchior, JR; Roberts, DC | 1 |
| Levin, FR; Mariani, JJ | 1 |
| Akhondzadeh, S; Ashrafi, M; Jafarinia, M; Khajavi, D; Modabbernia, A; Mohammadi, MR; Tabrizi, M; Yadegari, N | 1 |
| Chevassus, H; Costa, F; Farret, A; Gagnol, JP; Galtier, F; Petit, P; Ponçon, CA; Roux, C | 1 |
| Brensilver, M; Heinzerling, KG; Shoptaw, S | 1 |
| Liechti, ME; Simmler, LD; Wandeler, R | 1 |
| Capellà, D; Castells, X; Farre, M; Pérez-Mañá, C; Torrens, M | 1 |
| Anagnostaras, SG; Carmack, SA; Howell, KK; Rasaei, K; Reas, ET | 1 |
| Locatelli, I; Munda, B; Stuhec, M; Svab, V | 1 |
| Hansen, R; Rodriguez-Monguio, R; Seoane-Vazquez, E | 1 |
| Ng, QX | 1 |
| Adamo, N; Atkinson, LZ; Banaschewski, T; Barbui, C; Bhatti, S; Carucci, S; Cipriani, A; Coghill, D; Cortese, S; Del Giovane, C; Hayes, AJ; Mohr-Jensen, C; Purgato, M; Shokraneh, F; Simonoff, E; Steinhausen, HC; Xia, J; Zuddas, A | 1 |
| Adamo, N; Atkinson, LZ; Banaschewski, T; Barbui, C; Carucci, S; Cipriani, A; Coghill, D; Cortese, S; Del Giovane, C; Hayes, AJ; Hollis, C; Mohr-Jensen, C; Purgato, M; Shokraneh, F; Simonoff, E; Steinhausen, HC; Tessari, L; Xia, J; Zuddas, A | 1 |
| Su, CC; Tsai, CY; Tsai, IJ; Tsai, TH | 1 |
| Bai, Z; Charach, A; Chojecki, D; Eagles, C; Elliott, J; Hossain, A; Hsieh, SC; Husereau, D; Johnston, A; Kelly, SE; Mamdani, M; Skidmore, B; Tsakonas, E; Wells, GA | 1 |
| Golden, EC; Millman, RP; Schenck, CH | 1 |
| Cândido, RCF; Golder, S; Junqueira, DR; Menezes de Padua, CA | 1 |
20 review(s) available for bupropion and methylphenidate
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Monoamine oxidase inhibitors and atypical antidepressants.
Topics: Aged; Antidepressive Agents; Bupropion; Depressive Disorder; Fluoxetine; Humans; Methylphenidate; Monoamine Oxidase Inhibitors; Psychiatric Status Rating Scales; Trazodone | 1992 |
Attention-deficit/hyperactivity disorder: a life-span perspective.
Topics: Adolescent; Adult; Age Factors; Antidepressive Agents, Tricyclic; Attention Deficit Disorder with Hyperactivity; Bupropion; Child; Comorbidity; Dextroamphetamine; Drug Therapy, Combination; Female; Humans; Male; Mental Disorders; Methylphenidate; Pemoline; Sex Factors | 1998 |
Psychopharmacology of ADHD: children and adolescents.
Topics: Adolescent; Age Factors; Amphetamines; Antidepressive Agents, Tricyclic; Attention Deficit Disorder with Hyperactivity; Bupropion; Central Nervous System Stimulants; Child; Cyclohexanols; Dextroamphetamine; Drug Administration Schedule; Fluoxetine; Humans; Methylphenidate; Monoamine Oxidase Inhibitors; Pemoline; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride | 1998 |
Ephedrine and other stimulants as ergogenic aids.
Topics: Amphetamine; Bupropion; Cocaine; Dopamine Uptake Inhibitors; Doping in Sports; Ephedrine; Humans; Methylphenidate; Sports; Sympathomimetics | 2003 |
Evidence-based pharmacotherapy for attention-deficit hyperactivity disorder.
Topics: Adrenergic alpha-Agonists; Adrenergic Uptake Inhibitors; Adult; Antidepressive Agents; Antidepressive Agents, Second-Generation; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Bupropion; Central Nervous System Stimulants; Child; Clonidine; Delayed-Action Preparations; Evidence-Based Medicine; Guanfacine; Humans; Methylphenidate; Propylamines | 2004 |
Pharmacological management of attention-deficit hyperactivity disorder.
Topics: Adrenergic alpha-Agonists; Amphetamines; Antidepressive Agents; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Bupropion; Central Nervous System Stimulants; Child; Clonidine; Guanfacine; Humans; Methylphenidate; Propylamines | 2004 |
Attention deficit hyperactivity disorder and substance use disorders.
Topics: Adolescent; Attention Deficit Disorder with Hyperactivity; Bupropion; Central Nervous System Stimulants; Child; Comorbidity; Conduct Disorder; Humans; Methylphenidate; Risk Factors; Substance-Related Disorders | 2008 |
Pharmacotherapy of methamphetamine addiction: an update.
Topics: Antipsychotic Agents; Aripiprazole; Bupropion; Central Nervous System Stimulants; Dextroamphetamine; Drug Therapy; Humans; Lobeline; Methamphetamine; Methylphenidate; Narcotic Antagonists; Nicotinic Agonists; Piperazines; Prevalence; Quinolones; Recurrence; Substance-Related Disorders | 2008 |
Attention-deficit-hyperactivity disorder: an update.
Topics: Adolescent; Adrenergic Uptake Inhibitors; Adult; Amphetamine; Antidepressive Agents, Second-Generation; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Bupropion; Case-Control Studies; Central Nervous System Stimulants; Child; Conduct Disorder; Follow-Up Studies; Humans; Juvenile Delinquency; Longitudinal Studies; Methylphenidate; Patient Compliance; Prescriptions; Prevalence; Propylamines; Substance-Related Disorders; Time Factors; Treatment Outcome; United States | 2009 |
Agonist-like pharmacotherapy for stimulant dependence: preclinical, human laboratory, and clinical studies.
Topics: Animals; Behavior Therapy; Benzhydryl Compounds; Bupropion; Central Nervous System Stimulants; Clinical Trials as Topic; Cognition; Dextroamphetamine; Humans; Levodopa; Methylphenidate; Modafinil; Substance-Related Disorders | 2010 |
[Diagnosis and treatment of attention deficit hyperactivity disorder in adults].
Topics: Adult; Amphetamines; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Automobile Driving; Behavior Therapy; Bupropion; Central Nervous System Stimulants; Combined Modality Therapy; Comorbidity; Dextroamphetamine; Diagnostic Self Evaluation; Educational Status; Female; Humans; Interpersonal Relations; Interview, Psychological; Lisdexamfetamine Dimesylate; Male; Methylphenidate; Neuropsychological Tests; Occupations; Propylamines; Quality of Life; Severity of Illness Index; Symptom Assessment | 2012 |
Psychostimulant treatment of cocaine dependence.
Topics: Amphetamines; Animals; Benzhydryl Compounds; Bupropion; Central Nervous System Stimulants; Clinical Trials as Topic; Cocaine; Cocaine-Related Disorders; Combined Modality Therapy; Dopamine Agents; Humans; Methylphenidate; Modafinil; Placebos; Rats; Reinforcement, Psychology; United States | 2012 |
Pharmacotherapy of amphetamine-type stimulant dependence: an update.
Topics: Amphetamine; Amphetamine-Related Disorders; Animals; Bupropion; Central Nervous System Stimulants; Humans; Methylphenidate; Naltrexone; Randomized Controlled Trials as Topic | 2013 |
Efficacy of psychostimulant drugs for amphetamine abuse or dependence.
Topics: Amphetamine-Related Disorders; Benzhydryl Compounds; Bupropion; Central Nervous System Stimulants; Dextroamphetamine; Humans; Methylphenidate; Modafinil; Randomized Controlled Trials as Topic | 2013 |
Comparative efficacy and acceptability of atomoxetine, lisdexamfetamine, bupropion and methylphenidate in treatment of attention deficit hyperactivity disorder in children and adolescents: a meta-analysis with focus on bupropion.
Topics: Adolescent; Adrenergic Uptake Inhibitors; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Bupropion; Central Nervous System Stimulants; Child; Comparative Effectiveness Research; Dextroamphetamine; Double-Blind Method; Female; Humans; Lisdexamfetamine Dimesylate; Male; Methylphenidate; Patient Acceptance of Health Care; Propylamines; Randomized Controlled Trials as Topic; Treatment Outcome | 2015 |
A Systematic Review of the Use of Bupropion for Attention-Deficit/Hyperactivity Disorder in Children and Adolescents.
Topics: Adolescent; Attention Deficit Disorder with Hyperactivity; Bupropion; Child; Dopamine Uptake Inhibitors; Humans; Methylphenidate; Randomized Controlled Trials as Topic | 2017 |
Comparative efficacy and tolerability of medications for attention-deficit hyperactivity disorder in children, adolescents, and adults: a systematic review and network meta-analysis.
Topics: Adolescent; Adrenergic alpha-2 Receptor Agonists; Adult; Attention Deficit Disorder with Hyperactivity; Bupropion; Central Nervous System Stimulants; Child; Clonidine; Dose-Response Relationship, Drug; Humans; Methylphenidate; Network Meta-Analysis; Randomized Controlled Trials as Topic | 2018 |
Pharmacologic treatment of attention deficit hyperactivity disorder in adults: A systematic review and network meta-analysis.
Topics: Adult; Amphetamine; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Bayes Theorem; Bupropion; Central Nervous System Stimulants; Dextroamphetamine; Drug-Related Side Effects and Adverse Reactions; Female; Guanfacine; Humans; Lisdexamfetamine Dimesylate; Male; Methylphenidate; Modafinil; Network Meta-Analysis; Quality of Life; Randomized Controlled Trials as Topic | 2020 |
Immediate-release methylphenidate for attention deficit hyperactivity disorder (ADHD) in adults.
Topics: Adult; Antidepressive Agents, Second-Generation; Anxiety; Attention Deficit Disorder with Hyperactivity; Bias; Bupropion; Central Nervous System Stimulants; Depression; Drug Delivery Systems; Female; Flavonoids; Humans; Lithium Compounds; Male; Methylphenidate; Middle Aged; Placebos; Plant Extracts; Randomized Controlled Trials as Topic; Young Adult | 2021 |
10 trial(s) available for bupropion and methylphenidate
| Article | Year |
|---|---|
Bupropion treatment of attention-deficit hyperactivity disorder in adults.
Topics: Adult; Antidepressive Agents; Attention Deficit Disorder with Hyperactivity; Bupropion; Clinical Trials as Topic; Dextroamphetamine; Female; Follow-Up Studies; Humans; Male; Methylphenidate; Monoamine Oxidase Inhibitors; Propiophenones | 1990 |
Bupropion versus methylphenidate in the treatment of attention-deficit hyperactivity disorder.
Topics: Adolescent; Attention Deficit Disorder with Hyperactivity; Bupropion; Child; Cross-Over Studies; Dose-Response Relationship, Drug; Double-Blind Method; Humans; Methylphenidate; Placebos; Treatment Outcome | 1995 |
Discriminative-stimulus and participant-rated effects of methylphenidate, bupropion, and triazolam in d-amphetamine-trained humans.
Topics: Adult; Affect; Blood Pressure; Bupropion; Dextroamphetamine; Discrimination, Psychological; Dopamine Uptake Inhibitors; Female; GABA Modulators; Heart Rate; Humans; Male; Methylphenidate; Middle Aged; Psychomotor Performance; Triazolam | 1998 |
Bupropion SR vs. methylphenidate vs. placebo for attention deficit hyperactivity disorder in adults.
Topics: Adrenergic Agents; Adult; Attention Deficit Disorder with Hyperactivity; Bupropion; Dopamine Uptake Inhibitors; Double-Blind Method; Female; Humans; Male; Methylphenidate; Neuropsychological Tests; Severity of Illness Index; Time Factors; Treatment Outcome | 2001 |
Bupropion treatment for cocaine abuse and adult attention-deficit/hyperactivity disorder.
Topics: Adult; Attention Deficit Disorder with Hyperactivity; Bupropion; Cocaine-Related Disorders; Comorbidity; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Male; Methylphenidate; Single-Blind Method; Treatment Outcome | 2002 |
Combination pharmacotherapy in children and adolescents with bipolar disorder.
Topics: Adolescent; Antidepressive Agents; Antimanic Agents; Antipsychotic Agents; Attention Deficit Disorder with Hyperactivity; Bipolar Disorder; Bupropion; Carbamazepine; Central Nervous System Stimulants; Child; Drug Therapy, Combination; Female; Humans; Lithium; Male; Methylphenidate; Prospective Studies; Risperidone; Selective Serotonin Reuptake Inhibitors; Valproic Acid | 2003 |
Blood pressure changes associated with medication treatment of adults with attention-deficit/hyperactivity disorder.
Topics: Adult; Amphetamines; Antidepressive Agents; Attention Deficit Disorder with Hyperactivity; Blood Pressure; Bupropion; Central Nervous System Stimulants; Cross-Over Studies; Desipramine; Female; Heart Rate; Humans; Hypertension; Male; Methylphenidate; Middle Aged; Pemoline; Placebos; Practice Guidelines as Topic | 2005 |
Treatment of methadone-maintained patients with adult ADHD: double-blind comparison of methylphenidate, bupropion and placebo.
Topics: Adult; Algorithms; Analgesics, Opioid; Antidepressive Agents, Second-Generation; Attention Deficit Disorder with Hyperactivity; Bupropion; Central Nervous System Stimulants; Comorbidity; Delayed-Action Preparations; Double-Blind Method; Humans; Male; Methadone; Methylphenidate; Opioid-Related Disorders; Time Factors | 2006 |
Bupropion versus methylphenidate in the treatment of children with attention-deficit/hyperactivity disorder: randomized double-blind study.
Topics: Adolescent; Attention Deficit Disorder with Hyperactivity; Bupropion; Child; Dopamine Uptake Inhibitors; Dose-Response Relationship, Drug; Double-Blind Method; Female; Follow-Up Studies; Headache; Humans; Male; Methylphenidate; Psychiatric Status Rating Scales; Treatment Outcome | 2012 |
Psychological and physiological effects of bupropion compared to methylphenidate after prolonged administration in healthy volunteers (NCT00285155).
Topics: Adult; Antidepressive Agents, Second-Generation; Blood Pressure; Body Temperature; Bupropion; Cognition; Cross-Over Studies; Dose-Response Relationship, Drug; Double-Blind Method; Energy Intake; Humans; Male; Methylphenidate; Psychomotor Performance; Time Factors; Young Adult | 2013 |
24 other study(ies) available for bupropion and methylphenidate
| Article | Year |
|---|---|
Relationship between brain tissue partitioning and microemulsion retention factors of CNS drugs.
Topics: Brain; Central Nervous System; Chromatography, Liquid; Emulsions; Mass Spectrometry | 2009 |
A novel photoaffinity ligand for the dopamine transporter based on pyrovalerone.
Topics: Cell Line, Tumor; Dopamine Plasma Membrane Transport Proteins; Humans; Ligands; Molecular Structure; Photoaffinity Labels; Pyrrolidines; Structure-Activity Relationship | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Experimental solubility profiling of marketed CNS drugs, exploring solubility limit of CNS discovery candidate.
Topics: Central Nervous System Agents; Drug Evaluation, Preclinical; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Solubility | 2010 |
Effects of cocaine and related drugs in nonhuman primates. III. Self-administration by squirrel monkeys.
Topics: Animals; Bupropion; Cocaine; Dopamine; Male; Mazindol; Methylphenidate; Neurotransmitter Uptake Inhibitors; Nomifensine; Piperazines; Propiophenones; Saimiri; Self Administration | 1989 |
Effects of acute and chronic bupropion on locomotor activity and dopaminergic neurons.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Antidepressive Agents; Bupropion; Corpus Striatum; Dextroamphetamine; Dopamine; Male; Methylphenidate; Motor Activity; Propiophenones; Rats; Rats, Inbred Strains; Time Factors | 1986 |
Drug alterations of punished responding after chlordiazepoxide: possible screen for agents useful in minimal brain dysfunction.
Topics: Animals; Attention Deficit Disorder with Hyperactivity; Bupropion; Chlordiazepoxide; Conditioning, Operant; Dextroamphetamine; Drug Evaluation, Preclinical; Humans; Imipramine; Male; Methylphenidate; Phenobarbital; Propiophenones; Punishment; Rats | 1981 |
Long-acting stimulants for the treatment of attention-deficit disorder in cocaine-dependent adults.
Topics: Adult; Algorithms; Amphetamines; Antidepressive Agents, Second-Generation; Attention Deficit Disorder with Hyperactivity; Bupropion; Central Nervous System Stimulants; Cocaine-Related Disorders; Delayed-Action Preparations; Diagnosis, Dual (Psychiatry); Drug Therapy, Combination; Fluoxetine; Humans; Methylphenidate; Outcome Assessment, Health Care; Pemoline | 2000 |
Pharmacokinetic interactions between cyclosporine and bupropion or methylphenidate.
Topics: Antidepressive Agents, Second-Generation; Attention Deficit Disorder with Hyperactivity; Bupropion; Central Nervous System Stimulants; Child; Cyclosporine; Drug Interactions; Heart Transplantation; Humans; Immunosuppressive Agents; Male; Methylphenidate | 2001 |
Bupropion-methylphenidate combination and grand mal seizures.
Topics: Adolescent; Attention Deficit Disorder with Hyperactivity; Bupropion; Depressive Disorder; Dose-Response Relationship, Drug; Drug Therapy, Combination; Epilepsy, Tonic-Clonic; Humans; Male; Methylphenidate | 2002 |
Hidden amphetamines: from smoking cessation to diabetes.
Topics: Amphetamines; Appetite Depressants; Bronchodilator Agents; Bupropion; Central Nervous System Stimulants; Drug Approval; Ephedra; Ephedrine; Fenfluramine; France; Humans; Methylphenidate; Phenylpropanolamine; Plant Structures | 2004 |
Acute myocardial infarction in a young male on methylphenidate, bupropion, and erythromycin.
Topics: Adolescent; Anti-Bacterial Agents; Antidepressive Agents, Second-Generation; Bupropion; Central Nervous System Stimulants; Drug Interactions; Electrocardiography; Erythromycin; Humans; Male; Methylphenidate; Myocardial Infarction | 2005 |
Effects of methylphenidate and bupropion on DHEA-S and cortisol plasma levels in attention-deficit hyperactivity disorder.
Topics: Antidepressive Agents, Second-Generation; Attention Deficit Disorder with Hyperactivity; Biomarkers; Bupropion; Central Nervous System Stimulants; Child; Dehydroepiandrosterone Sulfate; Humans; Hydrocortisone; Korea; Male; Methylphenidate; Treatment Outcome | 2008 |
Nicotine as a conditioned stimulus: impact of attention-deficit/hyperactivity disorder medications.
Topics: Animals; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Behavior, Animal; Bupropion; Cocaine; Conditioning, Operant; Conditioning, Psychological; Discrimination Learning; Dopamine Uptake Inhibitors; Dose-Response Relationship, Drug; Generalization, Psychological; Male; Methylphenidate; Nicotine; Nicotinic Antagonists; Piperazines; Propylamines; Rats; Rats, Sprague-Dawley | 2007 |
Challenges and opportunities in establishing scientific and regulatory standards for assuring therapeutic equivalence of modified-release products: workshop summary report.
Topics: Bupropion; Chemistry, Pharmaceutical; Delayed-Action Preparations; Drug and Narcotic Control; Drug Approval; Methylphenidate; Pyridines; Therapeutic Equivalency; United States; United States Food and Drug Administration; Zolpidem | 2010 |
Comparison of the effects of methamphetamine, bupropion, and methylphenidate on the self-administration of methamphetamine by rhesus monkeys.
Topics: Animals; Bupropion; Central Nervous System Stimulants; Conditioning, Operant; Dopamine Uptake Inhibitors; Dose-Response Relationship, Drug; Feeding Behavior; Macaca mulatta; Male; Methamphetamine; Methylphenidate; Motivation; Self Administration; Substance-Related Disorders | 2011 |
Cocaine self-administration produces pharmacodynamic tolerance: differential effects on the potency of dopamine transporter blockers, releasers, and methylphenidate.
Topics: Animals; Bupropion; Cocaine; Dopamine; Dopamine Plasma Membrane Transport Proteins; Dopamine Uptake Inhibitors; Dose-Response Relationship, Drug; Drug Tolerance; Male; Methylphenidate; Nomifensine; Rats; Rats, Sprague-Dawley; Self Administration | 2012 |
Bupropion, methylphenidate, and 3,4-methylenedioxypyrovalerone antagonize methamphetamine-induced efflux of dopamine according to their potencies as dopamine uptake inhibitors: implications for the treatment of methamphetamine dependence.
Topics: Amphetamine-Related Disorders; Benzodioxoles; Biological Transport; Bupropion; Dopamine; Humans; Methamphetamine; Methylphenidate; Pyrrolidines; Synthetic Cathinone | 2013 |
Animal model of methylphenidate's long-term memory-enhancing effects.
Topics: Adrenergic Uptake Inhibitors; Amphetamine; Animals; Atomoxetine Hydrochloride; Bupropion; Central Nervous System Stimulants; Citalopram; Cocaine; Conditioning, Classical; Dose-Response Relationship, Drug; Fear; Female; Locomotion; Male; Maze Learning; Memory, Long-Term; Methylphenidate; Mice; Mice, Inbred C57BL; Nootropic Agents; Propylamines; Reinforcement, Psychology; Selective Serotonin Reuptake Inhibitors; Space Perception | 2014 |
Interchangeability, Safety and Efficacy of Modified-Release Drug Formulations in the USA: The Case of Opioid and Other Nervous System Drugs.
Topics: Analgesics, Opioid; Antidepressive Agents, Second-Generation; Bupropion; Centers for Medicare and Medicaid Services, U.S.; Central Nervous System Agents; Central Nervous System Stimulants; Chemistry, Pharmaceutical; Delayed-Action Preparations; Drug Overdose; Drugs, Generic; Humans; Methylphenidate; Product Surveillance, Postmarketing; Psychotropic Drugs; Risk Assessment; Therapeutic Equivalency; United States; United States Food and Drug Administration | 2016 |
Comparative efficacy and tolerability of pharmacological interventions for attention-deficit/hyperactivity disorder in children, adolescents and adults: protocol for a systematic review and network meta-analysis.
Topics: Adolescent; Adrenergic alpha-2 Receptor Agonists; Adult; Attention Deficit Disorder with Hyperactivity; Bupropion; Central Nervous System Stimulants; Child; Clinical Protocols; Clonidine; Dose-Response Relationship, Drug; Humans; Methylphenidate; Network Meta-Analysis; Treatment Outcome | 2017 |
Incidence and risk of attention-deficit hyperactivity disorder in children with amblyopia: A nationwide cohort study.
Topics: Adrenergic Uptake Inhibitors; Amblyopia; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Bupropion; Child; Cohort Studies; Databases, Factual; Dopamine Uptake Inhibitors; Female; Humans; Incidence; Male; Methylphenidate; National Health Programs; Risk Factors; Taiwan; Visual Acuity | 2019 |
Adult attention deficit/hyperactivity disorder in the ambulatory care setting: Erratum.
Topics: Ambulatory Care; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Bupropion; Contraindications, Drug; Dopamine; Feeding and Eating Disorders; Humans; Methylphenidate; Norepinephrine | 2020 |
Treatment of severe morning sleep inertia with bedtime long-acting bupropion and/or long-acting methylphenidate in a series of 4 patients.
Topics: Adolescent; Adult; Aged; Bupropion; Female; Humans; Male; Methylphenidate; Middle Aged; Polysomnography; Quality of Life; Sleep | 2021 |